Caleres Shares Face Mounting Pressure as Analyst Concerns Deepen

The downward trajectory for Caleres shares shows no signs of abating. The footwear company’s stock declined another 2.0 percent in recent trading, closing at $12.57. This continued weakness follows the latest confirmation of a “Sell” rating from Weiss Ratings and reflects persistent investor anxiety following disappointing quarterly results.

Multiple Analyst Warnings Signal Trouble

Market experts are sounding alarms about Caleres’s deteriorating position. Two prominent research firms have issued clear sell recommendations in recent weeks. Weiss Ratings reaffirmed its “Sell (D+)” assessment on Saturday, while Zacks Research had already downgraded the stock to “Strong Sell” in late August. The consensus from analysts is unmistakable: investors should avoid this equity.

The financial performance tells a concerning story. During the second quarter, Caleres fell significantly short of profit expectations. Instead of the anticipated $0.51 per share, the company reported earnings of just $0.35 per share—a substantial $0.16 miss. Although revenue of $658.52 million slightly exceeded projections, this still represented a 3.6 percent decrease compared to the same period last year.

Structural Challenges Compound Quarterly Weakness

Several fundamental issues are driving the persistent decline:

Should investors sell immediately? Or is it worth buying Caleres?

• The average price target sits at just $14.00 alongside sell recommendations
• S&P downgraded the company’s rating to ‘BB-‘ due to increased debt levels
• The $120.2 million Stuart Weitzman acquisition continues to weigh on the balance sheet
• Management’s suspension of full-year guidance serves as a red flag for investors

The current weakness period comes as no surprise to attentive market observers. The September release of second-quarter figures initially triggered a selling frenzy, with shares plunging 11.27 percent, followed by an additional 16.59 percent drop in pre-market trading. The company’s underlying operational challenges appear to have persisted since that time.

December Quarterly Report Pivotal for Recovery Hopes

All eyes now turn to the next quarterly results scheduled for early December. The critical question remains whether Caleres can stage a recovery or faces further declines. Structural problems—from elevated debt burdens to weak operational performance—provide little room for optimism.

The footwear manufacturer is navigating challenging market conditions. While proposed annual cost savings of $15 million and supply chain diversification efforts could theoretically provide support, the decisive factor remains whether these measures will prove sufficient to reverse the negative trend.